Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-07 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |